Catalyst Pharmaceutical
CPRX
CPRX
229 hedge funds and large institutions have $1.09B invested in Catalyst Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 66 increasing their positions, 67 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
229
Holders Change
+41
Holders Change %
+21.81%
% of All Funds
3.96%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
66
Increased
66
Reduced
67
Closed
23
Calls
$2.9M
Puts
$2.32M
Net Calls
+$583K
Net Calls Change
+$9K
Top Buyers
| 1 |
BlackRock
New York
|
$196M |
| 2 |
DM
Deerfield Management
New York
|
$62.8M |
| 3 |
State Street
Boston,
Massachusetts
|
$96.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$78.8M |
| 5 |
Two Sigma Investments
New York
|
$22.3M |
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
$8.45M |
| 2 |
Millennium Management
New York
|
$18.5M |
| 3 |
Goldman Sachs
New York
|
$9.24M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.46M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
$5.02M |
